Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2002
11/27/2002EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259618A2 Human enzyme molecules
11/27/2002EP1259615A1 Human antibodies against eotaxin and their use
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259515A2 Thienopyridine derivatives and their use as anti-inflammatory agents
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002EP1259259A2 Mucosal adjuvant formulation
11/27/2002EP1259256A1 Antigenic complexes and methods
11/27/2002EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002EP1259231A2 Naphthoquinone derivatives as cd45 inhibitors
11/27/2002EP1259222A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
11/27/2002EP1259125A1 Inulin products with improved nutritional properties
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0862557B1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS
11/27/2002EP0804210B1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/27/2002EP0708648B1 Inhibition of nitric oxide production by retinoic acid
11/27/2002EP0700402B1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
11/27/2002EP0627933B1 Bystander suppression of autoimmune diseases
11/27/2002EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions
11/27/2002CN1382158A Multiple cytokine-antibody complexes
11/27/2002CN1382157A Therapeutic compounds comprised of anti-FC receptor binding agents
11/27/2002CN1382153A 重组亚单位疫苗 Recombinant subunit vaccine
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002CN1382055A Remedies
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1381582A Targetting high-expression recombinant adenovirus of human granulocyte-macrophage colony stimulating factor and its preparing process and usage
11/27/2002CN1381501A Tumor necrosis factor inhibiting peptide and its application
11/27/2002CN1381261A Liquid immunopotentiator for baby
11/27/2002CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002CN1094929C Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/26/2002US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002US6486311 Peanut allergens and methods
11/26/2002US6486209 Use for 1,3-propanediol derivatives
11/26/2002US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
11/26/2002US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002US6486183 Antivirals
11/26/2002US6486135 Nucleic acid respiratory syncytial virus vaccines
11/26/2002US6486132 Immunomodulator, immunomodulator food and immunomodulator feed
11/26/2002US6486124 Mixture of cyclosporin a and fatty ester
11/26/2002US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002US6485955 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
11/26/2002US6485929 Method for inhibiting CD95-independent apoptosis in AIDS
11/26/2002US6485755 Methods of using electron active compounds for managing cancer
11/26/2002US6485725 Room temperature storable immunoglobulin preparation for intravenous injection
11/26/2002CA2257142C 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
11/26/2002CA2111573C Cadherin materials and methods
11/26/2002CA2102889C Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
11/26/2002CA2087164C Target specific antibody-superantigen conjugates and their preparation
11/26/2002CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/26/2002CA2078555C Novel vitamin d analogues
11/26/2002CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/22/2002CA2383004A1 Non-anaphylactogenic ige vaccines
11/21/2002WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002WO2002092808A1 Random gene unidirectional antisense library
11/21/2002WO2002092807A1 Unigene unidirectional antisense library
11/21/2002WO2002092795A2 Intracellular bonding of costimulatory molecules
11/21/2002WO2002092793A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes
11/21/2002WO2002092792A2 Antigen-dependent reduction of specific immune responses by influencing co-stimulation
11/21/2002WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002WO2002092762A2 Cytokine polypeptides
11/21/2002WO2002092759A2 Molecules for disease detection and treatment
11/21/2002WO2002092632A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002WO2002092620A2 Peptides and related molecules that bind to tall-1
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092558A1 Polythiourea lipid derivatives
11/21/2002WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002WO2002092540A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002WO2002092131A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002WO2002092125A1 Compositions for use in treating ige-associated disorders
11/21/2002WO2002092091A1 Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
11/21/2002WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002WO2002092075A2 Therapeutic delivery of carbon monoxide
1 ... 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 ... 1172